CDK9 Regulates AR Promoter Selectivity and Cell Growth through Serine 81 Phosphorylation
Vicki L. Gordon, Daniel Gioeli(George Mason University)
Cited by 134
Related Papers
Compensatory Pathways Induced by MEK Inhibition Are Effective Drug Targets for Combination Therapy against Castration-Resistant Prostate Cancer
|Molecular Cancer Therapeutics|2011|66